Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 2
1991 1
1994 1
1996 2
1997 2
1998 2
1999 1
2000 3
2001 1
2002 1
2003 1
2004 1
2005 5
2006 2
2007 3
2008 1
2009 3
2010 4
2011 2
2012 10
2013 4
2014 4
2015 3
2016 4
2017 9
2018 5
2019 2
2020 7
2021 8
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

90 results
Results by year
Filters applied: . Clear all
Page 1
Advances of small molecule targeting of kinases.
Berndt N, Karim RM, Schönbrunn E. Berndt N, et al. Among authors: schonbrunn e. Curr Opin Chem Biol. 2017 Aug;39:126-132. doi: 10.1016/j.cbpa.2017.06.015. Epub 2017 Jul 18. Curr Opin Chem Biol. 2017. PMID: 28732278 Free PMC article. Review.
Tetrahydroindazole inhibitors of CDK2/cyclin complexes.
Lee JC, Hong KH, Becker A, Tash JS, Schönbrunn E, Georg GI. Lee JC, et al. Among authors: schonbrunn e. Eur J Med Chem. 2021 Mar 15;214:113232. doi: 10.1016/j.ejmech.2021.113232. Epub 2021 Jan 31. Eur J Med Chem. 2021. PMID: 33550184
Dihydropyridine Lactam Analogs Targeting BET Bromodomains.
Jiang J, Sigua LH, Chan A, Kalra P, Pomerantz WCK, Schönbrunn E, Qi J, Georg GI. Jiang J, et al. Among authors: schonbrunn e. ChemMedChem. 2022 Jan 5;17(1):e202100407. doi: 10.1002/cmdc.202100407. Epub 2021 Dec 21. ChemMedChem. 2022. PMID: 34932262
Tumor-derived CK1α mutations enhance MDMX inhibition of p53.
Liu X, Huang Q, Chen L, Zhang H, Schonbrunn E, Chen J. Liu X, et al. Among authors: schonbrunn e. Oncogene. 2020 Jan;39(1):176-186. doi: 10.1038/s41388-019-0979-z. Epub 2019 Aug 28. Oncogene. 2020. PMID: 31462704 Free PMC article.
An Advanced Tool To Interrogate BRD9.
Karim RM, Schönbrunn E. Karim RM, et al. Among authors: schonbrunn e. J Med Chem. 2016 May 26;59(10):4459-61. doi: 10.1021/acs.jmedchem.6b00550. Epub 2016 Apr 27. J Med Chem. 2016. PMID: 27120693
EP300 selectively controls the enhancer landscape of MYCN-amplified neuroblastoma.
Durbin AD, Wang T, Wimalasena VK, Zimmerman MW, Li D, Dharia NV, Mariani L, Shendy NAM, Nance S, Patel AG, Shao Y, Mundada M, Maxham L, Park PMC, Sigua LH, Morita K, Saur Conway A, Robichaud AL, Perez-Atayde AR, Bikowitz MJ, Quinn TR, Wiest OG, Easton J, Schonbrunn E, Bulyk ML, Abraham BJ, Stegmaier K, Look AT, Qi J. Durbin AD, et al. Among authors: schonbrunn e. Cancer Discov. 2021 Nov 12:candisc.0385.2021. doi: 10.1158/2159-8290.CD-21-0385. Online ahead of print. Cancer Discov. 2021. PMID: 34772733 Free article.
90 results